Literature DB >> 11687459

Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales.

A Kassu1, A Tsegaye, B Petros, D Wolday, E Hailu, T Tilahun, B Hailu, M T Roos, A L Fontanet, D Hamann, T F De Wit.   

Abstract

Immunological values for 562 factory workers from Wonji, Ethiopia, a sugar estate 114 km southeast of the capital city, Addis Ababa, Ethiopia, were compared to values for 218 subjects from Akaki, Ethiopia, a suburb of Addis Ababa, for whom partial data were previously published. The following markers were measured: lymphocytes, T cells, B cells, NK cells, CD4(+) T cells, and CD8(+) T cells. A more in depth comparison was also made between Akaki and Wonji subjects. For this purpose, various differentiation and activation marker (CD45RA, CD27, HLA-DR, and CD38) expressions on CD4(+) and CD8(+) T cells were studied in 60 male, human immunodeficiency virus-negative subjects (30 from each site). Data were also compared with Dutch blood donor control values. The results confirmed that Ethiopians have significantly decreased CD4(+) T-cell counts and highly activated immune status, independent of the geographic locale studied. They also showed that male subjects from Akaki have significantly higher CD8(+) T-cell counts, resulting in a proportional increase in each of the CD8(+) T-cell compartments studied: naïve (CD45RA(+)CD27(+)), memory (CD45RA(-)CD27(+)), cytotoxic effector (CD45RA(+)CD27(-)), memory/effector (CD45RA(-)CD27(-)), activated (HLA-DR(+)CD38(+)), and resting (HLA-DR(-)CD38(-)). No expansion of a specific functional subset was observed. Endemic infection or higher immune activation is thus not a likely cause of the higher CD8 counts in the Akaki subjects. The data confirm and extend earlier observations and suggest that, although most lymphocyte subsets are comparable between the two geographical locales, there are also differences. Thus, care should be taken in extrapolating immunological reference values from one population group to another.

Entities:  

Mesh:

Year:  2001        PMID: 11687459      PMCID: PMC96245          DOI: 10.1128/CDLI.8.6.1171-1176.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  39 in total

1.  Diagnosis of strongyloidiasis: importance of Baermann's method.

Authors:  J P LIMA; P G DELGADO
Journal:  Am J Dig Dis       Date:  1961-09

2.  Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.

Authors:  M K Maini; R J Gilson; N Chavda; S Gill; A Fakoya; E J Ross; A N Phillips; I V Weller
Journal:  Genitourin Med       Date:  1996-02

3.  Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood.

Authors:  B W Lee; H K Yap; F T Chew; T C Quah; K Prabhakaran; G S Chan; S C Wong; C C Seah
Journal:  Cytometry       Date:  1996-03-15

4.  T-cell dynamics of immunodeficiency.

Authors:  M Roederer
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

5.  Influence of race, age and sex on the lymphocyte subsets in peripheral blood of healthy Malaysian adults.

Authors:  M L Choong; S H Ton; S K Cheong
Journal:  Ann Clin Biochem       Date:  1995-11       Impact factor: 2.057

6.  Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults.

Authors:  K M Kam; W L Leung; M Y Kwok; M Y Hung; S S Lee; W P Mak
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

7.  Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells.

Authors:  P A Baars; M M Maurice; M Rep; B Hooibrink; R A van Lier
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

8.  Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?

Authors:  Z Bentwich; Z Weisman; C Moroz; S Bar-Yehuda; A Kalinkovich
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

9.  CD8 naive T cell counts decrease progressively in HIV-infected adults.

Authors:  M Roederer; J G Dubs; M T Anderson; P A Raju; L A Herzenberg; L A Herzenberg
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 10.  Immune activation is a dominant factor in the pathogenesis of African AIDS.

Authors:  Z Bentwich; A Kalinkovich; Z Weisman
Journal:  Immunol Today       Date:  1995-04
View more
  35 in total

1.  Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population.

Authors:  Ilka Engelmann; Ulrike Moeller; Andrea Santamaria; Peter G Kremsner; Adrian J F Luty
Journal:  Immunology       Date:  2006-09-20       Impact factor: 7.397

2.  Immunohematological reference values for healthy adults in Burkina Faso.

Authors:  N Klose; B Coulibaly; D M Tebit; F Nauwelaers; H P Spengler; G Kynast-Wolf; B Kouyaté; H-G Kräusslich; T Böhler
Journal:  Clin Vaccine Immunol       Date:  2007-04-18

3.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Authors:  Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

4.  Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude?

Authors:  C Abuye; A Tsegaye; C E West; P Versloot; E J Sanders; D Wolday; D Hamann; T F Rinke De Wit; A L Fontanet
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

5.  Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Authors:  Sabine M Hermans; Agnes N Kiragga; Petra Schaefer; Andrew Kambugu; Andy I M Hoepelman; Yukari C Manabe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

6.  Association of vitamin A deficiency with decrease in TNF-α expressing CD3-CD56+ NK cells in Ghanaians.

Authors:  Yi Jiang; Francis Obuseh; William Ellis; Chandrika Piyathilake; Pauline Jolly
Journal:  Nutr Res       Date:  2007-07       Impact factor: 3.315

7.  Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.

Authors:  Arnoldo Barbosa; Denise Naniche; John J Aponte; M Nelia Manaca; Inacio Mandomando; Pedro Aide; Jahit Sacarlal; Montse Renom; Sarah Lafuente; W Ripley Ballou; Pedro L Alonso
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

8.  Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania.

Authors:  Bernard J Ngowi; Sayoki G Mfinanga; Johan N Bruun; Odd Morkve
Journal:  BMC Infect Dis       Date:  2009-01-13       Impact factor: 3.090

9.  CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

Authors:  Etienne Karita; Nzeera Ketter; Matt A Price; Kayitesi Kayitenkore; Pontiano Kaleebu; Annet Nanvubya; Omu Anzala; Walter Jaoko; Gaudensia Mutua; Eugene Ruzagira; Joseph Mulenga; Eduard J Sanders; Mary Mwangome; Susan Allen; Agnes Bwanika; Ubaldo Bahemuka; Ken Awuondo; Gloria Omosa; Bashir Farah; Pauli Amornkul; Josephine Birungi; Sarah Yates; Lisa Stoll-Johnson; Jill Gilmour; Gwynn Stevens; Erin Shutes; Olivier Manigart; Peter Hughes; Len Dally; Janet Scott; Wendy Stevens; Pat Fast; Anatoli Kamali
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240

10.  Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa.

Authors:  Wilson L Mandala; Jenny M MacLennan; Esther N Gondwe; Steven A Ward; Malcolm E Molyneux; Calman A MacLennan
Journal:  J Allergy Clin Immunol       Date:  2009-11-26       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.